Circulation, Vol 65, 1230-1235, Copyright © 1982 by American Heart Association
A Matsumori and C Kawai
Severe myocarditis was induced in inbred BALB/c mice inoculated with the M
variant of encephalomyocarditis (EMC) virus. The mortality rate was maximal
on the fourth day, then decreased gradually, but increased again between
the eleventh and fourteenth days. Gross myocardial lesions were seen on the
surface of the ventricles in 62 of 125 mice (49.6%) after the fifth day.
These myocardial lesions were observed more frequently in the dead mice (46
of 49, 93.9%). Cavity dimensions and wall thickness were measured in two
groups of mice with myocarditis. On days 5-7, the cavity dimensions of the
right (RV) and left (LV) ventricles in inoculated mice (0.92 +/- 0.51 mm
and 1.21 +/- 0.18 mm, respectively) were significantly larger than those in
controls (RV 0.54 +/- 0.17, LV 1.01 +/- 0.15; p less than 0.05). The wall
thickness of the RV (0.46 +/- 0.09, controls 0.64 +/- 0.11; p less than
0.001) and the LV (0.97 +/- 0.13, controls 1.12 +/- 0.19; p less than 0.05)
was significantly decreased. On days 8-14, dilatation of the LV was more
pronounced (1.48 +/- 0.37, p less than 0.005) than during days 5-7, and the
interventricular septum was also thinner. Pleural effusion, ascites and
congestion of the lungs and liver were noted, and death seemed due to
congestive heart failure. This study is the first documentation of
congestive heart failure after viral infection is an experimental animal.
ARTICLES
An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice
This article has been cited by other articles:
 |
|
 |
|
  H. Higuchi, M. Hara, K. Yamamoto, T. Miyamoto, M. Kinoshita, T. Yamada, K. Uchiyama, and A. Matsumori Mast Cells Play a Critical Role in the Pathogenesis of Viral Myocarditis Circulation, July 22, 2008; 118(4): 363 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yamamoto, T. Shioi, K. Uchiyama, T. Miyamoto, S. Sasayama, and A. Matsumori Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice J. Am. Coll. Cardiol., December 3, 2003; 42(11): 2000 - 2006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nishio, T. Shioi, S. Sasayama, and A. Matsumori Carvedilol increases the production of interleukin-12 and interferon-{gamma} and improves the survival of mice infected with the encephalomyocarditis virus J. Am. Coll. Cardiol., January 15, 2003; 41(2): 340 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nishio, S. Sasayama, and A. Matsumori Left ventricular pressure-volume relationship in a murine model of congestive heart failure due to acute viral myocarditis J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1506 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Miyamoto, A. Matsumori, M.-W. Hwang, R. Nishio, H. Ito, and S. Sasayama Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1713 - 1718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wada, K. Saito, T. Kanda, I. Kobayashi, H. Fujii, S. Fujigaki, N. Maekawa, H. Takatsu, H. Fujiwara, K. Sekikawa, et al. Tumor Necrosis Factor-{{alpha}} (TNF-{{alpha}}) Plays a Protective Role in Acute Viral Myocarditis in Mice : A Study Using Mice Lacking TNF-{{alpha}} Circulation, February 6, 2001; 103(5): 743 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nishio, A. Matsumori, T. Shioi, H. Ishida, and S. Sasayama Treatment of Experimental Viral Myocarditis With Interleukin-10 Circulation, September 7, 1999; 100(10): 1102 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nishio, A. Matsumori, T. Shioi, W. Wang, T. Yamada, K. Ono, and S. Sasayama Denopamine, a {beta}1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-{alpha} production in the heart J. Am. Coll. Cardiol., September 1, 1998; 32(3): 808 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Hasenfuss Animal models of human cardiovascular disease, heart failure and hypertrophy Cardiovasc Res, July 1, 1998; 39(1): 60 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Matsumori, K. Ono, R. Nishio, Y. Nose, and S. Sasayama Amiodarone Inhibits Production of Tumor Necrosis Factor-{alpha} by Human Mononuclear Cells : A Possible Mechanism for its Effect in Heart Failure Circulation, September 2, 1997; 96(5): 1386 - 1389. [Abstract] [Full Text]
|
|
|
|
|
|
W. Z. Wang, A. Matsumori, T. Yamada, T. Shioi, I. Okada, S. Matsui, Y. Sato, H. Suzuki, K. Shiota, and S. Sasayama Beneficial Effects of Amlodipine in a Murine Model of Congestive Heart Failure Induced by Viral Myocarditis: A Possible Mechanism Through Inhibition of Nitric Oxide Production Circulation, January 7, 1997; 95(1): 245 - 251. [Abstract] [Full Text]
|
|